| | | | | | | | | | |
|
|
| Dockets Entered
On January 11, 2006
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1999D-2145
|
| VICH GL11 on Impurities in New Veterinary Medicinal Products
|
|
|
| 2002N-0273
|
| Animal Proteins Prohibited in Ruminant Feed
|
|
|
| 2003E-0259
|
| Patent Extension Extension for Geodon or Zeldox (ziprasidone HCl monohydrate), 4,831,031
|
|
|
| 2003N-0161
|
| Medical Devices;Reprocessed Single-Use Devices;Termination
|
|
|
| 2004E-0021
|
| Patent Extension, XOLAIR (omalizumab), U.S. Patent No. 6,267,958
|
|
|
| 2004E-0304
|
| Patent Extension for S8 Over-the-Wire System (Driver Stent Delivery System), U.S. Patent No. 5,292,331
|
|
|
| 2004E-0307
|
| Patent Extension for Altima (pemetrexed), U.S. Patent No. 5,344,932
|
|
|
| 2004E-0389
|
| Patent Extension for SURPASS (diclofenac sodium), U.S. Patent No. 4,937,078
|
|
|
| 2004E-0394
|
| Patent Extension for ALOXI (palonosetron hydrochloride) injection, U.S. Patent No. 5,202,333
|
|
|
| 2004E-0445
|
| Patent Extension for HUMIRA (adalimumab), U.S. Patent No. 6,090,382
|
|
|
| 2005D-0069
|
| Guidance for Industry and FDA Staff; Class II Special Controls Guidance Document: Instrumentation for Clinical Multiplex Test Systems
|
|
|
| 2005D-0219
|
| Guidance for Industry: General Principles for Evaluating the Safety of Compounds Used in Food-Producing Animals
|
|
|
| 2005D-0330
|
| Guidance for Industry and FDA Review Staff on Collection of Platelets by Automated Methods
|
|
|
| 2005D-0337
|
| Guidance for Industry and Food and Drug Administration; Class II Special Controls Guidance Document: Oral Rinse to Reduce the Adhesion of Dental Plaque
|
|
|
| 2005D-0483
|
| Guidance for Industry and Food and Drug Administration: Requesting an Extension to Use Existing Label Stock after the Trans Fat Labeling Effective Date of January 1, 2006
|
|
|
| 2005E-0233
|
| Patent Extension for OMACOR (EPA ethyl ester and DHA ethyl ester), U.S. Patent No. 5,502,077
|
|
|
| 2005E-0247
|
| Patent Term Extension Application for Omacor, U.S. Patent No. 5,698,594
|
|
|
| 2005E-0249
|
| Patent Term Extension Application for Enablex, U.S. Patent No. 5,096,890
|
|
|
| 2005E-0254
|
| Patent Extension Application for ERBITUX, U.S. Patent No. 6,217,866
|
|
|
| 2005E-0258
|
| Patent Term Extension Application for OMACOR, U.S. Patent No. 5, 656,667
|
|
|
| 2005N-0120
|
| Agency Information Collection Activities: Proposed Collection; Comment Request;
|
|
|
| 2005N-0209
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Food Contact Substances Notification System
|
|
|
| 2005N-0343
|
| Agency Emergency Processing Under OMB Review; Guidance for Requesting an Extension to Use Existing Label Stock after the Trans Fat Labeling Effective Date of January 1, 2006
|
|
|
| 2005N-0354
|
| Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
|
|
|
| 2005N-0394
|
| FDAs Communication of Drug Safety Information; Public Hearing
|
|
|
| 2005N-0413
|
| Assessing Consumer Perceptions of Health Claims; Public Meeting; Request for Comments
|
|
|
| 2005N-0416
|
| Food Allergen Labeling Notification (FALN): Extensively Hydrolyzed Casein
|
|
|
| 2005N-0510
|
| Anti-Counterfeit Drug Initiative Workshop and Vendor Display
|
|
|
| 2005P-0267
|
| Remove from label for propofol (Diprivan) the warning that propofol should be administered only by trained persons
|
|
|
| 2005P-0319
|
| Determination of PHENERGAN (Promethazine hydrochloride) 12.5mg and 50mg tablets
|
|
|
| 2005P-0352
|
| bioequivalence criteria be applied separately to oxybutynin and its active metabolite, desethyloxbutynin
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
| 1999D-2145
|
| VICH GL11 on Impurities in New Veterinary Medicinal Products
|
|
|
| GDL
3
|
| GUIDANCE
|
| Vol #:
|
| 1
|
|
|
| NAD
3
|
| FDA
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
|
| 2002N-0273
|
| Animal Proteins Prohibited in Ruminant Feed
|
|
|
| C
523
|
| Allen Co. Conservation District
|
| Vol #:
|
| 40
|
|
|
| 2003E-0259
|
| Patent Extension Extension for Geodon or Zeldox (ziprasidone HCl monohydrate), 4,831,031
|
|
|
| LET
3
|
| HFD-5 to the U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|
|
| 2003N-0161
|
| Medical Devices;Reprocessed Single-Use Devices;Termination
|
|
|
| C
7
|
| Association of Medical Device Reprocessors (AMDR)
|
| Vol #:
|
| 1
|
|
|
| 2004E-0021
|
| Patent Extension, XOLAIR (omalizumab), U.S. Patent No. 6,267,958
|
|
|
| LET
3
|
| HFD-5 to the U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|
|
| 2004E-0304
|
| Patent Extension for S8 Over-the-Wire System (Driver Stent Delivery System), U.S. Patent No. 5,292,331
|
|
|
| LET
4
|
| HFD-5 to the U.S. Patent and Tradmark Office
|
| Vol #:
|
| 1
|
|
|
| 2004E-0307
|
| Patent Extension for Altima (pemetrexed), U.S. Patent No. 5,344,932
|
|
|
| LET
3
|
| HFD-5 to the U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|
|
| 2004E-0389
|
| Patent Extension for SURPASS (diclofenac sodium), U.S. Patent No. 4,937,078
|
|
|
| LET
3
|
| HFD-5 to the U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|
|
| 2004E-0394
|
| Patent Extension for ALOXI (palonosetron hydrochloride) injection, U.S. Patent No. 5,202,333
|
|
|
| LET
3
|
| HFD-5 to the U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|
|
| 2004E-0445
|
| Patent Extension for HUMIRA (adalimumab), U.S. Patent No. 6,090,382
|
|
|
| LET
3
|
| HFD-5 to the U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|
|
| 2005D-0069
|
| Guidance for Industry and FDA Staff; Class II Special Controls Guidance Document: Instrumentation for Clinical Multiplex Test Systems
|
|
|
| EC
1
|
| Mr. Dave Lowe
|
| Vol #:
|
| 1
|
|
|
| 2005D-0219
|
| Guidance for Industry: General Principles for Evaluating the Safety of Compounds Used in Food-Producing Animals
|
|
|
| EC
6
|
| Miss. Melody Ruano
|
| Vol #:
|
| 1
|
|
|
| 2005D-0330
|
| Guidance for Industry and FDA Review Staff on Collection of Platelets by Automated Methods
|
|
|
| C
45
|
| Virginia Blood Services
|
| Vol #:
|
| 4
|
|
|
| 2005D-0337
|
| Guidance for Industry and Food and Drug Administration; Class II Special Controls Guidance Document: Oral Rinse to Reduce the Adhesion of Dental Plaque
|
|
|
| EC
3
|
| U.S. Food
|
| Vol #:
|
| 1
|
|
|
| 2005D-0483
|
| Guidance for Industry and Food and Drug Administration: Requesting an Extension to Use Existing Label Stock after the Trans Fat Labeling Effective Date of January 1, 2006
|
|
|
| GDL
2
|
| GUIDANCE
|
| Vol #:
|
| 1
|
|
|
| NAD
2
|
| FDA
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
|
| 2005E-0233
|
| Patent Extension for OMACOR (EPA ethyl ester and DHA ethyl ester), U.S. Patent No. 5,502,077
|
|
|
| LET
4
|
| HFD-5 to the U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|
|
| 2005E-0247
|
| Patent Term Extension Application for Omacor, U.S. Patent No. 5,698,594
|
|
|
| LET
4
|
| HFD-5 to the U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|
|
| 2005E-0249
|
| Patent Term Extension Application for Enablex, U.S. Patent No. 5,096,890
|
|
|
| LET
4
|
| HFD-5 to the U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|
|
| 2005E-0254
|
| Patent Extension Application for ERBITUX, U.S. Patent No. 6,217,866
|
|
|
| LET
4
|
| HFD-5 to The U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|
|
| 2005E-0258
|
| Patent Term Extension Application for OMACOR, U.S. Patent No. 5, 656,667
|
|
|
| LET
2
|
| HFD-5 to the U.S. Patent and Trademark Office
|
| Vol #:
|
| 1
|
|
|
| 2005N-0120
|
| Agency Information Collection Activities: Proposed Collection; Comment Request;
|
|
|
| NAL
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| SS
1
|
| SUPPORTING STATEMENT
|
| Vol #:
|
| 1
|
|
|
| 2005N-0209
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Food Contact Substances Notification System
|
|
|
| NAL
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| SS
1
|
| SUPPORTING STATEMENT
|
| Vol #:
|
| 1
|
|
|
| 2005N-0343
|
| Agency Emergency Processing Under OMB Review; Guidance for Requesting an Extension to Use Existing Label Stock after the Trans Fat Labeling Effective Date of January 1, 2006
|
|
|
| CR
1
|
| FUJI Natural Food, Inc. (FUJI)
|
| Vol #:
|
| 1
|
|
|
| 2005N-0354
|
| Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
|
|
|
| EC
407
|
| Mrs. Griselda Stein
|
| Vol #:
|
| 5
|
|
|
| EC
408
|
| Mr. John Herald
|
| Vol #:
|
| 5
|
|
|
| EC
409
|
| Academy of Managed Care Pharmacy
|
| Vol #:
|
| 5
|
|
|
| EC
410
|
| Mr. Ray Paradise
|
| Vol #:
|
| 5
|
|
|
| EC
411
|
| Mrs. Barbara Miller
|
| Vol #:
|
| 5
|
|
|
| EC
412
|
| Mrs. Elsa Saccoccio
|
| Vol #:
|
| 5
|
|
|
| EC
413
|
| Ms. Audrey Greve
|
| Vol #:
|
| 5
|
|
|
| EC
414
|
| Mr. Roberto Pietrosanti
|
| Vol #:
|
| 5
|
|
|
| EC
415
|
| Mrs. Karen DeLuca
|
| Vol #:
|
| 5
|
|
|
| EC
416
|
| Mrs. Barbara Olson
|
| Vol #:
|
| 5
|
|
|
| EC
417
|
| Mr. Nino Bilic
|
| Vol #:
|
| 5
|
|
|
| EC
418
|
| Miss. Janine Allington
|
| Vol #:
|
| 5
|
|
|
| EC
419
|
| Dr. Joshua Dyme
|
| Vol #:
|
| 5
|
|
| | | | | | | | |
|
|
| EC
420
|
| Mr. Dave Lowe
|
| Vol #:
|
| 5
|
|
|
| EC
421
|
| Mrs. Tracie Jerling
|
| Vol #:
|
| 5
|
|
|
| EC
422
|
| Ms. Liz Peters
|
| Vol #:
|
| 5
|
|
|
| 2005N-0394
|
| FDAs Communication of Drug Safety Information; Public Hearing
|
|
|
| C 5
|
| J. Locke
|
| Vol #:
|
| 2
|
|
|
| 2005N-0413
|
| Assessing Consumer Perceptions of Health Claims; Public Meeting; Request for Comments
|
|
|
| C
6
|
| National Nutritional Foods Association (NNFA)
|
| Vol #:
|
| 2
|
|
|
| TR
1
|
| November 17, 2005 Transcript
|
| Vol #:
|
| 3
|
|
|
| 2005N-0416
|
| Food Allergen Labeling Notification (FALN): Extensively Hydrolyzed Casein
|
|
|
| CR
1
|
| HFS-400 to Mead Johnson Nutritionals
|
| Vol #:
|
| 1
|
|
|
| LET
1
|
| HF-21 to Mead Johnson Nutritionals
|
| Vol #:
|
| 1
|
|
|
| 2005N-0510
|
| Anti-Counterfeit Drug Initiative Workshop and Vendor Display
|
|
|
| NM
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2005P-0267
|
| Remove from label for propofol (Diprivan) the warning that propofol should be administered only by trained persons
|
|
| EC
185
|
| Fredericksburg Anesthesia Associates
|
| Vol #:
|
| 3
|
|
|
| EC
186
|
| Anesthesia
|
| Vol #:
|
| 3
|
|
|
| 2005P-0319
|
| Determination of PHENERGAN (Promethazine hydrochloride) 12.5mg and 50mg tablets
|
|
|
| EC
1
Attachment
|
| Mr. Dave Lowe
|
| Vol #:
|
| 1
|
|
|
| EC
2
Attachment
|
| Mr. Dave Lowe
|
| Vol #:
|
| 1
|
|
|
| 2005P-0352
|
| bioequivalence criteria be applied separately to oxybutynin and its active metabolite, desethyloxbutynin
|
|
|
| EC
1
Attachment
|
| Mr. Dave Lowe
|
| Vol #:
|
| 2
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
| C 232
|
| J. Spaugh
|
| Vol #:
|
| 3
|
|
|
| C 233
|
| K. Lindsey
|
| Vol #:
|
| 3
|
|
|
| C 234
|
| Z. Bengali
|
| Vol #:
|
| 3
|
|
|
| C 235
|
| J. Lamphere
|
| Vol #:
|
| 3
|
|
|
| C 236
|
| J. Freeman
|
| Vol #:
|
| 3
|
|
|
| C 237
|
| B. Cleland
|
| Vol #:
|
| 3
|
|
|
| C 238
|
| C. Wunstiqu
|
| Vol #:
|
| 3
|
|
|
| C 239
|
| B. Haines
|
| Vol #:
|
| 3
|
|
|
| C 240
|
| K. Miller
|
| Vol #:
|
| 3
|
|
|
| C 241
|
| S. Gedda
|
| Vol #:
|
| 3
|
|
| | | | | | | |
|
|
| C 242
|
| M. Grover
|
| Vol #:
|
| 3
|
|
|
| C 243
|
| L. Vardaman
|
| Vol #:
|
| 3
|
|
|
| C 244
|
| B. Bunton
|
| Vol #:
|
| 3
|
|
|
| C 245
|
| D. Caudill
|
| Vol #:
|
| 3
|
|
|
| C 246
|
| Steven E. Pillow, M.D., P.A., FACOG & Associates
|
| Vol #:
|
| 3
|
|
|
| C 247
|
| V. Huttna
|
| Vol #:
|
| 3
|
|
|
| C 248
|
| S. Baker
|
| Vol #:
|
| 3
|
|
|
| C 249
|
| J. High
|
| Vol #:
|
| 3
|
|
|
| C 250
|
| L. William
|
| Vol #:
|
| 3
|
|
|
| C 251
|
| K. White
|
| Vol #:
|
| 3
|
|
|
| C 252
|
| B. Grgurich
|
| Vol #:
|
| 3
|
|
|
| C 253
|
| D. Harper
|
| Vol #:
|
| 3
|
|
|
| C 254
|
| D. Landers
|
| Vol #:
|
| 3
|
|
|
| EC
29
|
| Mr. Nathan Jefferson
|
| Vol #:
|
| 4
|
|
|
| EC
30
|
| Mrs. Jeanne Dimidio
|
| Vol #:
|
| 4
|
|
|
| EC
31
|
| Mrs. Sandra Villagrana
|
| Vol #:
|
| 4
|
|
|
| EC
32
|
| I'm also and RN
|
| Vol #:
|
| 4
|
|
|
| EC
33
|
| Ms. Melissa Curran
|
| Vol #:
|
| 4
|
|
|
| EC
34
|
| DNA Pharmacy Services
|
| Vol #:
|
| 4
|
|
|
| EC
35
|
| Mr. Michael Anneken
|
| Vol #:
|
| 4
|
|
|
| EC
36
|
| Mrs. Deborah Hawes
|
| Vol #:
|
| 4
|
|
|
| EC
37
|
| Ms. Evelyn Alexander
|
| Vol #:
|
| 4
|
|
|
| EC
38
|
| Rebecca J. Roberts, D.O.
|
| Vol #:
|
| 4
|
|
|
| EC
39
|
| Mrs. Susan Spille
|
| Vol #:
|
| 4
|
|
|
| EC
40
|
| Mrs. Lisa Sowry
|
| Vol #:
|
| 4
|
|
|
| EC
41
|
| Mrs. Rita Daughery
|
| Vol #:
|
| 4
|
|
|
| EC
42
|
| Ms. Claudia Rocklin
|
| Vol #:
|
| 4
|
|
|
| EC
43
|
| Mrs. Pamela Detrick
|
| Vol #:
|
| 4
|
|
|
| EC
44
|
| Mrs. Kathy Metz
|
| Vol #:
|
| 4
|
|
|
| EC
45
|
| Ms. Raylana Anderson
|
| Vol #:
|
| 4
|
|
|
| EC
46
|
| Mrs. Kim Collings
|
| Vol #:
|
| 4
|
|
|
| EC
47
|
| Campbell Family Medicine
|
| Vol #:
|
| 4
|
|
|
| EC
48
|
| Mrs. Jessica Wuebker
|
| Vol #:
|
| 4
|
|
|
| EC
49
|
| Mrs. GINA BENNIS
|
| Vol #:
|
| 4
|
|
|
| EC
50
|
| Mrs. Catherine Richardson
|
| Vol #:
|
| 4
|
|
|
| EC
51
|
| Mr. Guy Cass
|
| Vol #:
|
| 4
|
|
|
| EC
52
|
| Ms. Mary Snider
|
| Vol #:
|
| 4
|
|
| | | | | | | |
|
|
| EC
53
|
| Dr. Craig Jace
|
| Vol #:
|
| 4
|
|
|
| EC
54
|
| Dr. Lynn Leibowitz
|
| Vol #:
|
| 4
|
|
|
| EC
55
|
| Deines Pharmacy, Inc
|
| Vol #:
|
| 4
|
|
|
| EC
56
|
| Ms. marta strock
|
| Vol #:
|
| 4
|
|
|
| EC
57
|
| Mrs. Karen Lefkowitz
|
| Vol #:
|
| 4
|
|
|
| EC
58
|
| Mrs. Melanie Jakab
|
| Vol #:
|
| 4
|
|
|
| EC
59
|
| Mrs. Vicki Wright
|
| Vol #:
|
| 4
|
|
|
| EC
60
|
| Medical Lake
|
| Vol #:
|
| 4
|
|
|
| EC
61
|
| Mrs. Sally Sullenberger
|
| Vol #:
|
| 4
|
|
|
| EC
62
|
| Miss. Peggy Helmer
|
| Vol #:
|
| 4
|
|
|
| EC
63
|
| Mrs. Sue Bensadon
|
| Vol #:
|
| 4
|
|
|
| EC
64
|
| Mrs. Linda Cherry
|
| Vol #:
|
| 4
|
|
|
| EC
65
|
| Mrs. Marjorie Krofchok Krofchok
|
| Vol #:
|
| 4
|
|
|
| EC
66
|
| Ms. Kathleen Boyle
|
| Vol #:
|
| 4
|
|
|
| EC
67
|
| Ms. Margaret Fischel
|
| Vol #:
|
| 4
|
|
|
| EC
68
|
| Mrs. Krista Stump
|
| Vol #:
|
| 4
|
|
|
| EC
69
|
| Mrs. Donna Graves
|
| Vol #:
|
| 4
|
|
|
| EC
70
|
| Ms. Carol Kroening
|
| Vol #:
|
| 4
|
|
|
| EC
71
|
| Mrs. Kathleen Easton
|
| Vol #:
|
| 4
|
|
|
| EC
72
|
| Mrs. Janet Porges
|
| Vol #:
|
| 4
|
|
|
| EC
73
|
| Mrs. Dawn Hathaway
|
| Vol #:
|
| 4
|
|
|
| EC
74
|
| SELF/CONSUMERS
|
| Vol #:
|
| 4
|
|
|
| EC
75
|
| Mrs. Karla Evans
|
| Vol #:
|
| 4
|
|
|
| EC
76
|
| US citizen
|
| Vol #:
|
| 4
|
|
|
| EC
77
|
| Mrs. Shirley Slaughter
|
| Vol #:
|
| 4
|
|
|
| EC
78
|
| Ms. Diana Jacobsen
|
| Vol #:
|
| 4
|
|
|
| EC
79
|
| Dr. Janice Pemberton
|
| Vol #:
|
| 4
|
|
|
| EC
80
|
| Ms. Carolyn Wiant
|
| Vol #:
|
| 4
|
|
|
| EC
81
|
| Ms. Carolyn Wiant
|
| Vol #:
|
| 4
|
|
|
| EC
82
|
| Mrs. candace hamood
|
| Vol #:
|
| 4
|
|
|
| EC
83
|
| Ontario Pharmacy
|
| Vol #:
|
| 4
|
|
|
| EC
84
|
| Mrs. Scotti Nieukirk
|
| Vol #:
|
| 4
|
|
|
| EC
85
|
| Ms. Suzanne Kostic
|
| Vol #:
|
| 4
|
|
|
| EC
86
|
| Ms. Andrea McCaffrey
|
| Vol #:
|
| 4
|
|
|
| EC
87
|
| Ms. Glenda Maier
|
| Vol #:
|
| 4
|
|
|
| EC
88
|
| Mrs. Paula Cook
|
| Vol #:
|
| 4
|
|
|
| EC
89
|
| Mrs. Barbara Klimek
|
| Vol #:
|
| 4
|
|
| | | | | | | |
|
|
| EC
90
|
| Mrs. TAMMIE MOURADIAN
|
| Vol #:
|
| 4
|
|
|
| EC
91
|
| none
|
| Vol #:
|
| 4
|
|
|
| EC
92
|
| Miss. Lisa Denny
|
| Vol #:
|
| 4
|
|
|
| EC
93
|
| Mrs. Rayne Bordon
|
| Vol #:
|
| 4
|
|
|
| EC
94
|
| National Pharmacy Specialties
|
| Vol #:
|
| 4
|
|
|
| EC
95
|
| Ms. Diane DeVinney
|
| Vol #:
|
| 4
|
|
|
| EC
96
|
| Mrs. Janet Smith
|
| Vol #:
|
| 4
|
|
|
| EC
97
|
| Ms. a.m. angarola
|
| Vol #:
|
| 4
|
|
|
| EC
98
|
| Mrs. Shirley Harrison
|
| Vol #:
|
| 4
|
|
|
| EC
99
|
| Doane College
|
| Vol #:
|
| 4
|
|
|
| EC
100
|
| ElderWise Advocate
|
| Vol #:
|
| 4
|
|
|
| EC
101
|
| Mrs. Chris Lohry
|
| Vol #:
|
| 4
|
|
|
| EC
102
|
| Mrs. Joanne Allen
|
| Vol #:
|
| 4
|
|
|
| EC
103
|
| Mrs. Judy Schulz
|
| Vol #:
|
| 4
|
|
|
| EC
104
|
| Ms. Jennifer Huxoll
|
| Vol #:
|
| 4
|
|
|
| EC
105
|
| Mrs. Rosetta Mullen
|
| Vol #:
|
| 4
|
|
|
| EC
106
|
| Mrs. Rosetta Mullen
|
| Vol #:
|
| 4
|
|
|
| EC
107
|
| Mrs. Amy McCord
|
| Vol #:
|
| 4
|
|
|
| EC
108
|
| Ms. Helen Harrington
|
| Vol #:
|
| 4
|
|
|
| EC
109
|
| Ms. Susan Sorkenn
|
| Vol #:
|
| 4
|
|
|
| EC
110
|
| Mrs. Sara Hart
|
| Vol #:
|
| 4
|
|
|
| EC
111
|
| Mrs. Connie Watson
|
| Vol #:
|
| 4
|
|
|
| EC
112
|
| Ms. Melissa Folsom
|
| Vol #:
|
| 4
|
|
|
| EC
113
|
| Miss. Sheila Bachelor
|
| Vol #:
|
| 4
|
|
|
| EC
114
|
| Mrs. Lisa Thomas-Scheel
|
| Vol #:
|
| 4
|
|
|
| EC
115
|
| Mrs. Marcia Pomeroy
|
| Vol #:
|
| 4
|
|
|
| EC
116
|
| Mrs. Wanda McNally
|
| Vol #:
|
| 4
|
|
|
| EC
117
|
| Mrs. Rita Christopher
|
| Vol #:
|
| 4
|
|
|
| EC
118
|
| Ms. Amy Kelley
|
| Vol #:
|
| 4
|
|
|
| EC
119
|
| Mrs. Linda REason
|
| Vol #:
|
| 4
|
|
|
| EC
120
|
| None
|
| Vol #:
|
| 4
|
|
|
| EC
121
|
| Mrs. Joanne Prater
|
| Vol #:
|
| 4
|
|
|
| EC
122
|
| Mrs. Alice Dinicola
|
| Vol #:
|
| 4
|
|
|
| EC
123
|
| Mr. Scott Walsh
|
| Vol #:
|
| 4
|
|
|
| EC
124
|
| Mr. Scott Walsh
|
| Vol #:
|
| 4
|
|
|
| EC
125
|
| Ms. Nancy Sorensen-Kimmons
|
| Vol #:
|
| 4
|
|
|
| EC
126
|
| None
|
| Vol #:
|
| 4
|
|
| | | | | | | |
|
|
| EC
127
|
| Mrs. Janet Divitto
|
| Vol #:
|
| 4
|
|
|
| EC
128
|
| Mrs. Earlene Steele-Pridemore
|
| Vol #:
|
| 4
|
|
|
| EC
129
|
| Mrs. Cyndi Lepine
|
| Vol #:
|
| 4
|
|
|
| EC
130
|
| Miss. Karen Fletcher
|
| Vol #:
|
| 4
|
|
|
| EC
131
|
| Ms. Merri McLaughlin
|
| Vol #:
|
| 4
|
|
|
| EC
132
|
| Mrs. sharon King
|
| Vol #:
|
| 4
|
|
|
| EC
133
|
| Mrs. Amy Blum
|
| Vol #:
|
| 4
|
|
|
| EC
134
|
| Ms. Jan Hemmerling
|
| Vol #:
|
| 4
|
|
|
| EC
135
|
| Ms. Wendy Hannigan
|
| Vol #:
|
| 4
|
|
|
| EC
136
|
| Mrs. Deborah Rumford
|
| Vol #:
|
| 4
|
|
|
| EC
137
|
| Ms. Roslyn Cohen
|
| Vol #:
|
| 4
|
|
|